Valeritas Stock Price, News & Analysis (NASDAQ:VLRX)

$3.15 -0.05 (-1.56 %)
(As of 02/20/2018 06:39 AM ET)
Previous Close$3.20
Today's Range$3.05 - $3.15
52-Week Range$2.00 - $32.00
Volume2,600 shs
Average Volume11,976 shs
Market Capitalization$21.68 million
P/E RatioN/A
Dividend YieldN/A
Beta7.31

About Valeritas (NASDAQ:VLRX)

Valeritas logoValeritas, Inc. is a United States-based company, which is engaged in developing and commercializing treatment solutions that contribute to clinical outcomes for patients. The Company's portfolio includes V-Go disposable insulin delivery device, which is distributed through retail pharmacy. Its V-Go delivers insulin at a continuous preset basal rate and bolus dosing for adults with Type 2 diabetes requiring insulin. Its development portfolio also includes the h-Patch technology, the Mini-Ject pre-filled needle-free delivery system and the Micro-Trans microneedle transdermal delivery patch. Its h-Patch is a controlled delivery technology platform designed to deliver drugs into subcutaneous tissue. The Mini-Ject represents needle-free injection system, combining a range of fully disposable pre-filled options. Micro-Trans microneedle array patch technology enables drug delivery into the dermis without limitations of drug size, structure, charge or the patient's skin characteristics.

Receive VLRX News and Ratings via Email

Sign-up to receive the latest news and ratings for VLRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VLRX
CUSIPN/A
Phone908-927-9920

Debt

Debt-to-Equity Ratio3.54%
Current Ratio3.88%
Quick Ratio3.20%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$19.55 million
Price / Sales1.11
Cash FlowN/A
Price / CashN/A
Book Value($22.94) per share
Price / Book-0.14

Profitability

Trailing EPS($16.53)
Net Income$-46,360,000.00
Net Margins-229.55%
Return on Equity-820.08%
Return on Assets-76.57%

Miscellaneous

EmployeesN/A
Outstanding Shares6,880,000

Valeritas (NASDAQ:VLRX) Frequently Asked Questions

What is Valeritas' stock symbol?

Valeritas trades on the NASDAQ under the ticker symbol "VLRX."

How were Valeritas' earnings last quarter?

Valeritas Holdings, Inc. (NASDAQ:VLRX) issued its quarterly earnings results on Friday, May, 12th. The company reported ($6.92) EPS for the quarter, missing the Zacks' consensus estimate of ($2.72) by $4.20. The firm had revenue of $4.61 million for the quarter, compared to the consensus estimate of $4.64 million. Valeritas had a negative net margin of 229.55% and a negative return on equity of 820.08%. View Valeritas' Earnings History.

Where is Valeritas' stock going? Where will Valeritas' stock price be in 2018?

3 brokerages have issued 1-year target prices for Valeritas' stock. Their forecasts range from $10.00 to $12.00. On average, they expect Valeritas' share price to reach $11.00 in the next twelve months. View Analyst Ratings for Valeritas.

Who are some of Valeritas' key competitors?

When did Valeritas IPO?

(VLRX) raised $60 million in an initial public offering (IPO) on Thursday, March 23rd 2017. The company issued 6,000,000 shares at a price of $9.00-$11.00 per share. Cowen and Company and Wedbush PacGrow acted as the underwriters for the IPO and Roth Capital Partners and B. Riley & Co. were co-managers.

How do I buy Valeritas stock?

Shares of Valeritas can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Valeritas' stock price today?

One share of Valeritas stock can currently be purchased for approximately $3.15.

How big of a company is Valeritas?

Valeritas has a market capitalization of $21.68 million and generates $19.55 million in revenue each year. The company earns $-46,360,000.00 in net income (profit) each year or ($16.53) on an earnings per share basis.

How can I contact Valeritas?

Valeritas' mailing address is 750 ROUTE 202 SOUTH SUITE 600, BRIDGEWATER NJ, 08807. The company can be reached via phone at 908-927-9920 or via email at [email protected]


MarketBeat Community Rating for Valeritas (VLRX)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  75 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about Valeritas and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Valeritas (NASDAQ:VLRX) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.00$11.00$11.00$11.00
Price Target Upside: 62.20% upside62.20% upside62.20% upside62.20% upside

Valeritas (NASDAQ:VLRX) Consensus Price Target History

Price Target History for Valeritas (NASDAQ:VLRX)

Valeritas (NASDAQ:VLRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/10/2017WedbushInitiated CoverageOutperform -> Outperform$12.00HighView Rating Details
5/17/2017B. RileyReiterated RatingBuy$10.00LowView Rating Details
4/17/2017CowenInitiated CoverageOutperformHighView Rating Details
(Data available from 2/20/2016 forward)

Earnings

Valeritas (NASDAQ:VLRX) Earnings History and Estimates Chart

Earnings by Quarter for Valeritas (NASDAQ:VLRX)

Valeritas (NASDAQ VLRX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017Q3 2017($1.84)($1.62)ViewN/AView Earnings Details
8/11/2017Q2 2017($1.87)($1.83)$5.11 million$4.79 millionViewN/AView Earnings Details
5/12/2017Q1 2017($2.72)($6.92)$4.64 million$4.61 millionViewN/AView Earnings Details
2/21/2017Q4 2016($0.76)($0.77)$4.96 million$4.80 millionViewN/AView Earnings Details
11/10/2016Q3 2016($6.32)($5.60)ViewN/AView Earnings Details
8/10/2016Q2 2016($8.72)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Valeritas (NASDAQ:VLRX) Earnings Estimates

2018 EPS Consensus Estimate: ($3.34)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.84)($0.84)($0.84)
Q2 20181($0.83)($0.83)($0.83)
Q3 20181($0.82)($0.82)($0.82)
Q4 20181($0.85)($0.85)($0.85)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Valeritas (NASDAQ:VLRX)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Valeritas (NASDAQ VLRX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 5.85%
Insider Trades by Quarter for Valeritas (NASDAQ:VLRX)

Valeritas (NASDAQ VLRX) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/24/2017Joseph M MandatoDirectorBuy3,188$3.44$10,966.721,912View SEC Filing  
8/22/2017Joseph M MandatoDirectorBuy900$3.52$3,168.001,012View SEC Filing  
8/22/2017Matt NguygnInsiderBuy1,500$3.59$5,385.008,250View SEC Filing  
8/21/2017Joseph M MandatoDirectorBuy912$3.68$3,356.16112View SEC Filing  
8/18/2017John Edward TimberlakeInsiderBuy3,500$3.70$12,950.0031,037View SEC Filing  
5/31/2017John Edward TimberlakeInsiderBuy4,000$4.94$19,760.0027,037View SEC Filing  
5/22/2017Erick LuceraInsiderBuy1,500$4.95$7,425.004,000View SEC Filing  
5/18/2017Matt NguygnInsiderBuy1,000$4.73$4,730.006,000View SEC Filing  
5/17/2017John Edward TimberlakeInsiderBuy5,000$5.14$25,700.0023,037View SEC Filing  
3/28/2017Capital Royalty L.P.Major ShareholderBuy4,000,000$10.00$40,000,000.00View SEC Filing  
3/23/2017Brian K RobertsDirectorBuy800$10.00$8,000.00800View SEC Filing  
3/23/2017Erick LuceraCFOBuy3,000$10.00$30,000.003,000View SEC Filing  
3/23/2017Geoffrey JenkinsInsiderBuy600$10.00$6,000.006,850View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Valeritas (NASDAQ VLRX) News Headlines

Source:
DateHeadline
Valeritas Holdings, Inc. (VLRX) Expected to Announce Quarterly Sales of $5.60 MillionValeritas Holdings, Inc. (VLRX) Expected to Announce Quarterly Sales of $5.60 Million
www.americanbankingnews.com - February 17 at 1:50 AM
 Valeritas Holdings, Inc. (VLRX) Given $13.50 Average Target Price by Brokerages Valeritas Holdings, Inc. (VLRX) Given $13.50 Average Target Price by Brokerages
www.americanbankingnews.com - February 16 at 9:14 PM
Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration AlgorithmValeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Insulin Titration Algorithm
finance.yahoo.com - February 15 at 9:25 AM
Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Ins...Valeritas Presents Data Demonstrating V-Go® Wearable Insulin Delivery Device Significantly Reduces A1C and Insulin Requirements in Patients with Type 2 Diabetes, When Combined with a Simplified Ins...
finance.yahoo.com - February 15 at 9:25 AM
Valeritas to Host Investor Meetings at the 2018 BTIG Medical Technology, Life Science, and Diagnostic Tools ConferenceValeritas to Host Investor Meetings at the 2018 BTIG Medical Technology, Life Science, and Diagnostic Tools Conference
finance.yahoo.com - February 9 at 8:31 AM
Valeritas (VLRX) Upgraded to "Sell" by ValuEngineValeritas (VLRX) Upgraded to "Sell" by ValuEngine
www.americanbankingnews.com - February 4 at 12:44 PM
 Analysts Anticipate Valeritas Holdings, Inc. (VLRX) Will Post Quarterly Sales of $5.60 Million Analysts Anticipate Valeritas Holdings, Inc. (VLRX) Will Post Quarterly Sales of $5.60 Million
www.americanbankingnews.com - February 1 at 8:04 AM
 Valeritas Holdings, Inc. (VLRX) Given $13.50 Average Price Target by Brokerages Valeritas Holdings, Inc. (VLRX) Given $13.50 Average Price Target by Brokerages
www.americanbankingnews.com - January 30 at 7:32 AM
Valeritas Announces its V-Go® Wearable Insulin Delivery Device is now available in Puerto RicoValeritas Announces its V-Go® Wearable Insulin Delivery Device is now available in Puerto Rico
finance.yahoo.com - January 17 at 10:19 AM
Valeritas Holdings, Inc. (VLRX) Expected to Post Quarterly Sales of $5.60 MillionValeritas Holdings, Inc. (VLRX) Expected to Post Quarterly Sales of $5.60 Million
www.americanbankingnews.com - January 15 at 11:42 PM
-$1.69 Earnings Per Share Expected for Valeritas Holdings, Inc. (VLRX) This Quarter-$1.69 Earnings Per Share Expected for Valeritas Holdings, Inc. (VLRX) This Quarter
www.americanbankingnews.com - January 13 at 3:32 AM
Zacks: Brokerages Set $13.50 Price Target for Valeritas Holdings, Inc. (VLRX)Zacks: Brokerages Set $13.50 Price Target for Valeritas Holdings, Inc. (VLRX)
www.americanbankingnews.com - January 12 at 5:16 AM
Valeritas Appoints Joseph Saldanha as Chief Business OfficerValeritas Appoints Joseph Saldanha as Chief Business Officer
finance.yahoo.com - January 9 at 10:18 AM
Valeritas Reports Preliminary Full Year and Fourth Quarter 2017 Revenue ResultsValeritas Reports Preliminary Full Year and Fourth Quarter 2017 Revenue Results
finance.yahoo.com - January 8 at 10:35 AM
What Should You Know About Valeritas Holdings Inc’s (NASDAQ:VLRX) Future?What Should You Know About Valeritas Holdings Inc’s (NASDAQ:VLRX) Future?
finance.yahoo.com - January 2 at 5:21 PM
Zacks: Brokerages Anticipate Valeritas Holdings, Inc. (VLRX) Will Post Quarterly Sales of $5.54 MillionZacks: Brokerages Anticipate Valeritas Holdings, Inc. (VLRX) Will Post Quarterly Sales of $5.54 Million
www.americanbankingnews.com - December 29 at 1:50 PM
$5.54 Million in Sales Expected for Valeritas Holdings, Inc. (VLRX) This Quarter$5.54 Million in Sales Expected for Valeritas Holdings, Inc. (VLRX) This Quarter
www.americanbankingnews.com - December 29 at 1:50 PM
Zacks: Valeritas Holdings, Inc. (VLRX) Receives Consensus Recommendation of "Strong Buy" from AnalystsZacks: Valeritas Holdings, Inc. (VLRX) Receives Consensus Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - December 28 at 1:10 AM
Valeritas Holdings, Inc. (VLRX) Expected to Announce Earnings of -$1.69 Per ShareValeritas Holdings, Inc. (VLRX) Expected to Announce Earnings of -$1.69 Per Share
www.americanbankingnews.com - December 27 at 9:58 AM
Brokerages Expect Valeritas Holdings, Inc. (VLRX) to Announce ($1.69) EPSBrokerages Expect Valeritas Holdings, Inc. (VLRX) to Announce ($1.69) EPS
www.americanbankingnews.com - December 24 at 9:33 PM
Zacks: Valeritas Holdings, Inc. (VLRX) Given Average Rating of "Strong Buy" by AnalystsZacks: Valeritas Holdings, Inc. (VLRX) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - December 22 at 12:20 AM
Valeritas CEO Appears on Fox Business Network’s Top Morning ShowValeritas CEO Appears on Fox Business Network’s Top Morning Show
finance.yahoo.com - December 19 at 10:27 AM
Valeritas to Ring the Nasdaq Stock Market Closing Bell on December 19thValeritas to Ring the Nasdaq Stock Market Closing Bell on December 19th
finance.yahoo.com - December 18 at 10:48 AM
-$1.69 EPS Expected for Valeritas Holdings, Inc. (VLRX) This Quarter-$1.69 EPS Expected for Valeritas Holdings, Inc. (VLRX) This Quarter
www.americanbankingnews.com - December 9 at 11:40 PM
 Valeritas Holdings, Inc. (VLRX) Receives Consensus Rating of "Strong Buy" from Analysts Valeritas Holdings, Inc. (VLRX) Receives Consensus Rating of "Strong Buy" from Analysts
www.americanbankingnews.com - December 6 at 9:38 PM
 Valeritas Holdings, Inc. (VLRX) Receives Consensus Recommendation of "Strong Buy" from Analysts Valeritas Holdings, Inc. (VLRX) Receives Consensus Recommendation of "Strong Buy" from Analysts
www.americanbankingnews.com - December 3 at 9:26 AM
Valeritas (VLRX) Upgraded to Sell at ValuEngineValeritas (VLRX) Upgraded to Sell at ValuEngine
www.americanbankingnews.com - December 2 at 12:40 AM
Valeritas Holdings, Inc. (VLRX) Expected to Announce Quarterly Sales of $5.54 MillionValeritas Holdings, Inc. (VLRX) Expected to Announce Quarterly Sales of $5.54 Million
www.americanbankingnews.com - November 24 at 11:40 AM
What You Must Know About Valeritas Holdings Inc’s (VLRX) Financial StrengthWhat You Must Know About Valeritas Holdings Inc’s (VLRX) Financial Strength
finance.yahoo.com - November 22 at 4:51 PM
35 Stocks Moving In Wednesdays Mid-Day Session35 Stocks Moving In Wednesday's Mid-Day Session
feeds.benzinga.com - November 22 at 1:39 PM
40 Stocks Moving In Tuesdays Mid-Day Session40 Stocks Moving In Tuesday's Mid-Day Session
feeds.benzinga.com - November 21 at 1:40 PM
Zacks: Valeritas Holdings, Inc. (VLRX) Given $13.50 Average Price Target by AnalystsZacks: Valeritas Holdings, Inc. (VLRX) Given $13.50 Average Price Target by Analysts
www.americanbankingnews.com - November 18 at 9:14 AM
Q4 2017 EPS Estimates for Valeritas Holdings, Inc. Raised by Zacks Investment Research (VLRX)Q4 2017 EPS Estimates for Valeritas Holdings, Inc. Raised by Zacks Investment Research (VLRX)
www.americanbankingnews.com - November 17 at 10:12 PM
Valeritas Holdings (VLRX) CEO John Timberlake on Q3 2017 Results - Earnings Call TranscriptValeritas Holdings' (VLRX) CEO John Timberlake on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 6:11 PM
Valeritas Reports Third Quarter 2017 Financial ResultsValeritas Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 9 at 9:33 AM
Edited Transcript of VLRX earnings conference call or presentation 8-Nov-17 9:30pm GMTEdited Transcript of VLRX earnings conference call or presentation 8-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 9:33 AM
Valeritas’ V-Go® Wearable Insulin Delivery Device, Combined with a Simplified Insulin Titration Algorithm, Demonstrates Significant Reductions in A1C and Insulin Requirements in Patients with Type 2 DiabetesValeritas’ V-Go® Wearable Insulin Delivery Device, Combined with a Simplified Insulin Titration Algorithm, Demonstrates Significant Reductions in A1C and Insulin Requirements in Patients with Type 2 Diabetes
finance.yahoo.com - November 3 at 10:00 AM
Valeritas to Present at the Canaccord Genuity Medical Technologies & Diagnostics ForumValeritas to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
finance.yahoo.com - October 28 at 7:53 AM
Valeritas to Report Third Quarter 2017 Results November 8, 2017Valeritas to Report Third Quarter 2017 Results November 8, 2017
feeds.benzinga.com - October 25 at 8:04 AM
$5.00 Million in Sales Expected for Valeritas Holdings, Inc. (VLRX) This Quarter$5.00 Million in Sales Expected for Valeritas Holdings, Inc. (VLRX) This Quarter
www.americanbankingnews.com - October 15 at 2:48 AM
Valeritas Holdings, Inc. (VLRX) Expected to Post Earnings of -$1.84 Per ShareValeritas Holdings, Inc. (VLRX) Expected to Post Earnings of -$1.84 Per Share
www.americanbankingnews.com - October 13 at 8:30 PM
Valeritas Wins Fourth Consecutive Cardinal Health Supply Chain Excellence AwardValeritas Wins Fourth Consecutive Cardinal Health Supply Chain Excellence Award
finance.yahoo.com - October 12 at 9:49 AM
When Will Valeritas Holdings Inc (VLRX) Need To Raise More Money?When Will Valeritas Holdings Inc (VLRX) Need To Raise More Money?
finance.yahoo.com - October 6 at 12:32 PM
Valeritas Announces Common Stock Purchase Agreement by Institutional Investor, Aspire Capital Fund, LLCValeritas Announces Common Stock Purchase Agreement by Institutional Investor, Aspire Capital Fund, LLC
finance.yahoo.com - September 23 at 10:47 AM
Valeritas Holdings, Inc.s (VLRX) Lock-Up Period Set To Expire  on September 19thValeritas Holdings, Inc.'s (VLRX) Lock-Up Period Set To Expire on September 19th
www.americanbankingnews.com - September 12 at 1:20 AM
Valeritas to Present Results of the Prospective Pragmatic Multicenter Clinical Trial of V-Go® Wearable Insulin Delivery Device to the European Diabetes CommunityValeritas to Present Results of the Prospective Pragmatic Multicenter Clinical Trial of V-Go® Wearable Insulin Delivery Device to the European Diabetes Community
finance.yahoo.com - September 6 at 9:57 AM
Valeritas to Present Results of the Prospective Pragmatic Multicenter Clinical Trial of V-Go® Wearable Insulin Delivery Device to the European Diabetes CommunityValeritas to Present Results of the Prospective Pragmatic Multicenter Clinical Trial of V-Go® Wearable Insulin Delivery Device to the European Diabetes Community
finance.yahoo.com - September 6 at 9:57 AM
Valeritas to Present at the Liolios 6th Annual Gateway ConferenceValeritas to Present at the Liolios 6th Annual Gateway Conference
finance.yahoo.com - August 29 at 9:30 AM
Valeritas Holdings, Inc. :VLRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Valeritas Holdings, Inc. :VLRX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 3:29 PM
VLRX: New Marketing Strategy Producing Strong Growth of Targeted AccountsVLRX: New Marketing Strategy Producing Strong Growth of Targeted Accounts
finance.yahoo.com - August 25 at 12:19 PM

SEC Filings

Valeritas (NASDAQ:VLRX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Valeritas (NASDAQ:VLRX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Valeritas (NASDAQ VLRX) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.